Global Genotyping Market to Reach US$ 36.75 Billion by 2027, Propelled by Increasing Demand for Genotypic-based Diagnostics

August 23, 2022

According to the latest report by IMARC Group, titled "Genotyping Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global genotyping market reached a value of US$ 14.77 Billion in 2021. Genotyping is a laboratory-based analytical approach that analyzes deoxyribonucleic acid (DNA) sequences to determine the genetic composition in genotypes of various living organisms, such as plants, animals, and microorganisms. It uses a set of biological tests that assists in comparing a single sample with the other sequences and noting the differences between individuals by using genetic history data of an individual, determining the fatherhood and motherhood, and preventing the spread of pathogens by tracking the origin of the outbreak. Genetic evaluations allow examiners to assess genetic make-up and several deviations, including significant structural changes in DNA and single nucleotide polymorphisms, by identifying genetic differences through biological assays. Apart from this, genotyping offers high efficiency, operational flexibility, and access to multiple parameters in single testing; thus, it finds extensive applications in agricultural biotechnology, diagnostics, and research institutes.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Genotyping Market Trends:

The increasing demand for genotypic-based diagnostic testing and bioinformatics solutions in data analysis and the increasing prevalence of various genetic disorders are primarily driving the market growth. The adoption of genotyping in the healthcare industry helps practitioners make point-of-care decisions and develop personalized medicines by analyzing multiple markers and probes, detecting sample outliers, and identifying relevant genetic variations for implementation. In line with this, the extensive utilization of genotyping in pharmacogenomics, animal genetics, food hygiene determination, and atmospheric testing in distant places or industrial settings, forensics, and drug development to provide information for the practice of personalized medicine regarding the proper medication and dosage is acting as another growth-inducing factor.

Additionally, the rising health concerns and the sudden outbreak of the COVID-19 pandemic across the globe prompted pharmaceutical companies to introduce genotyping kits to detect SARS-CoV-2 variants, which is contributing to the market growth. Moreover, the advent of technologies that offer superior accuracy in disease diagnosis and the uptake of single nucleotide polymorphisms (SNP) genotyping for formulating effective medications are positively stimulating the market growth. Furthermore, significant improvements in the healthcare infrastructure have augmented the need for reagents in genotyping tests, which is impelling the market growth. Other factors, such as the escalating consumer awareness regarding the availability of personalized medicines and ongoing research and development (R&D) activities in the precision medicine research field, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 36.75 Billion by 2027, growing at a CAGR of 15.60% during 2022-2027.

Market Summary:

  • Based on the product and service, the market has been classified into instruments, reagents and kits, and software and services.
  • On the basis of technology, the market has been segregated into polymerase chain reaction (PCR), capillary electrophoresis, microarray, sequencing, mass spectrometry, and others.
  • Based on the application, the market has been segmented into pharmacogenomics, diagnostics and personalized medicine, agricultural biotechnology, animal genetics, and others.
  • On the basis of the end user, the market has been categorized into pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.
  • On a regional basis, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Global Genotyping Market to Reach US$ 36.75 Billion by 2027, Propelled by Increasing Demand for Genotypic-based Diagnostics
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More